CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. [PDF]
O'Steen S +14 more
europepmc +1 more source
Antibody-dependent cellular phagocytosis in cancer immunotherapy: research and perspectives. [PDF]
Gu Q +9 more
europepmc +1 more source
Dual-trigger model of CD20 escape: NONO regulation and cryptic splicing induced by transcript overload in pediatric B-ALL. [PDF]
Kermani M +6 more
europepmc +1 more source
Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis. [PDF]
Nakada T +8 more
europepmc +1 more source
Overcoming chemotherapy resistance in diffuse large B-cell lymphoma using multifunctional nanocarriers: current advances and clinical challenges. [PDF]
Li D, Ke X, Hu K.
europepmc +1 more source
CD20<sup>+</sup>FCRL4<sup>+</sup> B Cells Activate CD8<sup>+</sup> T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity. [PDF]
Zhang B +17 more
europepmc +1 more source
Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options. [PDF]
Roshandel E +7 more
europepmc +1 more source
Lymph node microenvironment remodeling unlocks local antibody-mediated B cell depletion. [PDF]
Garcia Z +11 more
europepmc +1 more source
Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma. [PDF]
Maher N +6 more
europepmc +1 more source
B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts. [PDF]
Lems S, Mazzei MG, Foks AC, McNamara CA.
europepmc +1 more source

